Related Experiment Video
Updated: Jan 29, 2026

Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
In-home physical frailty monitoring: relevance with respect to clinical tests
Aly Chkeir1, Jean-Luc Novella2, Moustapha Dramé3
1Institut Charles Delaunay, UMR CNRS 6281, Université de Technologie de Troyes (UTT), 12 Rue Marie Curie, CS 42060, F-10004, Troyes, France. aly.chkeir@utt.fr.
Background:
Frailty detection and remote monitoring are of major importance for slowing down, and/or even stopping the frailty process in home-dwelling older people. Taking the Fried's criteria as a reference, this work aims to compare the results produced by a technological set (ARPEGE Pack) with those obtained by usual clinical tests, as well as to discuss the ability of the Pack to be used for long-run frailty remote monitoring.
Methods:
194 participants were given a number of geriatric tests and asked to make use of the ARPEGE technological tools as well as reference clinical tools to feed Fried's indicators. Spearman or Pearson's correlation coefficients were used to compare the ARPEGE results to the reference ones, depending on data statistical characteristics.
Results:
Good correlations were obtained for measurements of weight (0.99), grip strength (0.89) and walking speed (0.79). Results are much less satisfactory for evaluation of physical activity and exhaustion (Spearman correlation coefficients 0.25 and 0.41, respectively).
Conclusion:
Correlations regarding weight, grip strength and walking speed confirm the validity of the data produced by the ARPEGE Pack to feed Fried's criteria. Assessing activity level and exhaustion from an abbreviated questionnaire is still questionable. However, for long-run monitoring other methods of evaluation can be explored. Beyond the quantitative results, the ARPEGE Pack has been proved to be acceptable and motivating in such a long-term frailty monitoring.
Related Concept Videos
Area Between Curves: Integrating With Respect to y
Area Between Curves: Integrating With Respect to x
Clinically Relevant Drug Product Specifications: Methods of Establishment
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

